全文获取类型
收费全文 | 2624篇 |
免费 | 271篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 92篇 |
妇产科学 | 43篇 |
基础医学 | 438篇 |
口腔科学 | 165篇 |
临床医学 | 302篇 |
内科学 | 551篇 |
皮肤病学 | 58篇 |
神经病学 | 215篇 |
特种医学 | 147篇 |
外科学 | 317篇 |
综合类 | 22篇 |
一般理论 | 3篇 |
预防医学 | 194篇 |
眼科学 | 51篇 |
药学 | 162篇 |
中国医学 | 3篇 |
肿瘤学 | 121篇 |
出版年
2023年 | 37篇 |
2022年 | 15篇 |
2021年 | 42篇 |
2020年 | 46篇 |
2019年 | 50篇 |
2018年 | 89篇 |
2017年 | 90篇 |
2016年 | 95篇 |
2015年 | 113篇 |
2014年 | 117篇 |
2013年 | 228篇 |
2012年 | 154篇 |
2011年 | 148篇 |
2010年 | 134篇 |
2009年 | 73篇 |
2008年 | 87篇 |
2007年 | 108篇 |
2006年 | 101篇 |
2005年 | 91篇 |
2004年 | 110篇 |
2003年 | 78篇 |
2002年 | 85篇 |
2001年 | 36篇 |
2000年 | 15篇 |
1999年 | 21篇 |
1998年 | 51篇 |
1997年 | 34篇 |
1996年 | 35篇 |
1995年 | 36篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 19篇 |
1991年 | 18篇 |
1990年 | 12篇 |
1989年 | 22篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 21篇 |
1985年 | 19篇 |
1984年 | 26篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 19篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1955年 | 39篇 |
1954年 | 90篇 |
1949年 | 22篇 |
1948年 | 17篇 |
排序方式: 共有2912条查询结果,搜索用时 890 毫秒
81.
Dr. Lars S. JØrgensen M.D. Uffe Raundahl M.D. Lars L. Knudsen M.S. Karin AksglÆde M.D. Per SØgaard Ph.D. 《Diseases of the colon and rectum》1991,34(7):594-599
A new aseptic colon resection by an invagination technique is presented. The bowel to be resected is invaginated down into the healthy intestine, and the anastomosis is sutured in one layer of continuous suture before transection by a diathermy wire, placed in the intestinal lumen via the anus. Sections of bowel that cannot be invaginated,e.g.,because of a tumor, are first removed by transection between pairs of cable ties, which close the lumen. Twenty dogs were operated on without receiving prophylactic antibiotics. In 10, the intestine was transected between cable ties. An imprint, taken from the anastomosis and subcutis, was cultured. The bacterial count at the anastomosis exceeded 100 in only three cases; in the subcutis, this was the case in one dog. One wound infection developed. Serial barium enemas at 1, 2, 3, and 4 weeks revealed no anastomotic leakage. One early death because of a total anastomotic dehiscence was encountered, and two dogs were killed because of wound dehiscence and anastomotic stricture, respectively. It is concluded that, in dogs, the method is easily and safely performed, but further experimental studies are needed.This study was supported with grants from Fonden til Laegevidenskabens Fremme, Kraeftens Bekaempelse, Sygekassernes Helsefond, and Aarhus Universitets Forskningsfond. 相似文献
82.
S. KØlvraa N. Gregersen E. Christensen K. Rasmussen 《Journal of inherited metabolic disease》1980,3(1):63-66
A 1-year-old boy with a typical B12-responsive form of methylmalonic acidaemia was hospitalized twice due to acute bacterial infections. On both occasions, the
child was lethargic with a severe ketoacidosis on admission. Intensive therapy with protein restriction, intravenous administration
of electrolytes and antibiotics was effective within 4 days on both occasions. The urinary excretion of organic acids showed
the same pattern on both occasions. There were rising excretion concentrations, reaching a peak value within the first 24-hour
period, for the following compounds: 3-hydroxybutyric acid, 3-hydroxypropionic acid, 3-hydroxyisobutyric acid and 3-hydroxyisovaleric
acid. Excretion concentrations of the following rose for 48 h: isobutyric acid, 2-methylbutyric acid, isovaleric acid, lactic
acid and the 2-oxo-acids.
There was no increase until 12–24 h after the onset of severe illness in the excretion of propionic acid and methylmalonic
acid. Propionic acid excretion was maximal at about 48 h, while peak excretion of methylmalonic acid was delayed until about
72 h after the onset of severe illness; at this time there was clinical improvement. The biochemical implications of this
excretion pattern are discussed.
This work has been supported by a grant from the Danish Medical Research Council. 相似文献
83.
84.
85.
86.
We evaluated weight changes in obese patients at 6‐months after they ended participation in a 12‐month randomised controlled trial in which they received daily placebo, zonisamide 200 mg or zonisamide 400 mg, in addition to lifestyle counselling. Of the originally randomised 225 patients, 218 completed month‐12 when study interventions were discontinued. For the 154 patients who returned for 6‐month follow‐up off‐treatment, weight changes between month‐12 and month‐18 for placebo (n = 53), zonisamide 200 mg (n = 49) and zonisamide 400 mg groups (n = 52) were 0.5 kg [95% confidence interval (CI), ?0.8 to 1.8; 0.7%], 1.5 kg (0.2–2.8; 1.6%; p = 0.26 vs. placebo) and 2.4 kg (1.1–3.7; 2.6%; p = 0.04 vs. placebo), respectively. Our results suggest that although zonisamide 400 mg daily for 12‐months resulted in greater weight loss than with placebo, weight regain after discontinuation of interventions was greater in the zonisamide 400 mg group than placebo group. 相似文献
87.
88.
89.
Willingham SB Volkmer JP Gentles AJ Sahoo D Dalerba P Mitra SS Wang J Contreras-Trujillo H Martin R Cohen JD Lovelace P Scheeren FA Chao MP Weiskopf K Tang C Volkmer AK Naik TJ Storm TA Mosley AR Edris B Schmid SM Sun CK Chua MS Murillo O Rajendran P Cha AC Chin RK Kim D Adorno M Raveh T Tseng D Jaiswal S Enger PØ Steinberg GK Li G So SK Majeti R Harsh GR van de Rijn M Teng NN Sunwoo JB Alizadeh AA Clarke MF Weissman IL 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(17):6662-6667
CD47, a "don't eat me" signal for phagocytic cells, is expressed on the surface of all human solid tumor cells. Analysis of patient tumor and matched adjacent normal (nontumor) tissue revealed that CD47 is overexpressed on cancer cells. CD47 mRNA expression levels correlated with a decreased probability of survival for multiple types of cancer. CD47 is a ligand for SIRPα, a protein expressed on macrophages and dendritic cells. In vitro, blockade of CD47 signaling using targeted monoclonal antibodies enabled macrophage phagocytosis of tumor cells that were otherwise protected. Administration of anti-CD47 antibodies inhibited tumor growth in orthotopic immunodeficient mouse xenotransplantation models established with patient tumor cells and increased the survival of the mice over time. Anti-CD47 antibody therapy initiated on larger tumors inhibited tumor growth and prevented or treated metastasis, but initiation of the therapy on smaller tumors was potentially curative. The safety and efficacy of targeting CD47 was further tested and validated in immune competent hosts using an orthotopic mouse breast cancer model. These results suggest all human solid tumor cells require CD47 expression to suppress phagocytic innate immune surveillance and elimination. These data, taken together with similar findings with other human neoplasms, show that CD47 is a commonly expressed molecule on all cancers, its function to block phagocytosis is known, and blockade of its function leads to tumor cell phagocytosis and elimination. CD47 is therefore a validated target for cancer therapies. 相似文献
90.
Jianu CS Lange OJ Viset T Qvigstad G Martinsen TC Fougner R Kleveland PM Fossmark R Hauso Ø Waldum HL 《Scandinavian journal of gastroenterology》2012,47(1):64-67
We present a case of a gastric neuroendocrine carcinoma in a patient with a history of long-term proton pump inhibitor (PPI) use. A 49-year-old man using PPI for the last 15 years due to gastroesophageal reflux disease developed progressive dysphagia, dyspepsia and weight loss. Upper gastrointestinal endoscopy, endoscopic ultrasonography and abdominal CT diagnosed a malignant tumor localized to a hiatal hernia. Fasting serum chromogranin A and gastrin concentrations were elevated (32 nmol/l and 159 pmol/l, respectively). Helicobacter pylori PCR analysis of antral biopsies was negative. Biopsies from endoscopically normal oxyntic mucosa showed enterochromaffin-like (ECL) cell hyperplasia. Tumor biopsies revealed a poorly differentiated neuroendocrine carcinoma. Sevier-Munger staining, immunohistochemistry and electron microscopy indicated ECL cell as origin of the tumor cells. Concerns have previously been raised about the safety of long-term PPI use due to a possible increased risk of cancer. This case illustrates a patient with a poorly differentiated neuroendocrine carcinoma with ECL cell characteristics probably induced by hypergastrinemia secondary to long-term PPI use. 相似文献